New 6-nitroquinolones: Synthesis and antimicrobial activities

Farmaco

Volumn 59, Issue 6, 2004, Pages 463-471

  Sbardella, Gianluca ^a   Mai, Antonello ^b   Artico, Marino ^b   Setzu, Maria Giovanna ^c   Poni, Graziella ^c   La Colla, Paolo ^c  

^a UNIVERSITY OF SALERNO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antibacterial agents; Antimycobacterial agents; Nitroquinolones; Tuberculosis

Indexed keywords

1 CYCLOPROPYL 7 CYCLOPROPYLAMINO 1,4 DIHYDRO 6 NITRO 4 OXOQUINOLINE 3 CARBOXYLIC ACID; 1 TERT BUTYL 7 TERT BUTYLAMINO 1,4 DIHYDRO 6 NITRO 4 OXOQUINOLINE 3 CARBOXYLIC ACID; 1,4 DIHYDRO 1 ETHYL 7 ETHYLAMINO 6 NITRO 4 OXOQUINOLINE 3 CARBOXYLIC ACID; 6 AMINO 1 TERT BUTYL 7 TERT BUTYLAMINO 1,4 DIHYDRO 6 NITRO 4 OXOQUINOLINE 3 CARBOXYLIC ACID; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; CARBOXYLIC ACID DERIVATIVE; CIPROFLOXACIN; OFLOXACIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CIPROFLOXACIN; DRUG EVALUATION, PRECLINICAL; FLUOROQUINOLONES; ITALY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM TUBERCULOSIS; NITROQUINOLINES; OFLOXACIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2642513828     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.01.014     Document Type: Article

References (36)

1. Billo N.E. Global aspects of tuberculosis. Gangadharam P.R.J., Jenkins P.A. Mycobacteria II Chemotherapy. 1998;1-14 Chapman & Hall, New York
2. World Health Organization. Report On Global Tuberculosis Control. :2000;. Geneva [Online]
3. Churchyard G.J., Grant A.D. HIV infection, tuberculosis and non-tuberculous mycobacteria. South African Med. J. 91:2000;472-476
4. Manabe Y.C., Bishai W.R. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat. Med. 6:2000;1327-1329
5. Coninx R., Mathieu C., Debacker M., Mirzoev F., Ismaelov A., de Haller R., Meddings D.R. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet. 353:1999;969-973
6. Moore R.D., Chaisson R.E. Cost-Effectiveness of Prophylaxis for Mycobacterium avium Complex Disease. Am. J. Med. 102:(5, S 3):1997;50-55
7. Petrini B., Hoffner S. Drug-resistant and multidrug-resistant tubercle bacilli. Int. J. Antimicrob. Agents. 13:1999;93-97
8. Hamilton C.D. Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis. Curr. Infect. Dis. Rep. 1:1999;80-88
9. Migliori G.B., Ambrosetti M., Fattorini L., Penati V., Vaccarino P., Besozzi G., Ortona L., Saltini C., Orefici G., Moro M.L., Lona E., Cassone A. Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. Int. J. Tuberc. Lung Dis. 4:(4):2000;940-946
10. Migliori G.B., Fattorini L., Vaccarino P., Besozzi G., Saltini C., Orefici G., Iona E., Matterelli A., Fiorentini F., Codecasa L.R., Casali L., Cassone A. Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy. Int. J. Tuberc. Lung. Dis. 6:2002;32-38
11. Fitzgerald D.W., Morse M.M., Pape J.W., Johnson W.D. Jr. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis. Clin. Infect. Dis. 31:2000;1495-1497
12. De Smet K.A.L. Mycobacterium tuberculosis: beyond genome sequencing. Trends Microbiol. 5:1997;429-431
13. Jyoti S. Taking toll of TB. Trends Microbiol. 9:2001;255
14. Barry C.E.I. New horizons in the treatment of tuberculosis. Biochem. Pharmacol. 54:1997;1165-1172
15. Miletin M., Hartl J., Odlerova Z., Machacek M. Synthesis of some 2, 6-bis(alkylthio)-4-pyridine carboxamides and carboxythioamides and their antimycobacterial and antialgal activity. Pharmazie. 52:1997;558-560
16. Wachter G.A., Davis M.C., Martin A.R., Franzblau S.G. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. J. Med. Chem. 41:1998;2346-2348
17. Artico M., Mai A., Sbardella G., Massa S., Lampis G., Deidda D., Pompei R. N-[4-(1, 1'-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480. Bioorg. Med. Chem. Lett. 8:1998;1493-1498
18. Artico M., Mai A., Sbardella G., Massa S., Musiu C., Lostia S., Demontis F., La Colla P. Nitroquinolones with broad-spectrum antimycobacterial activity in vitro. Bioorg. Med. Chem. Lett. 9:1999;1651-1656
19. Jones P.B., Parrish N.M., Houston T.A., Stapon A., Bansal N.P., Dick J.D., Townsend C.A. A New Class of Antituberculosis Agents. J. Med. Chem. 43:2000;3304-3314
20. Bakkestuen A.K., Gundersen L.L., Langli G., Liu F., Nolsoe J.M.J. 9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 10:2000;1207-1210
21. Ragno R., Marshall G.R., Di Santo R., Costi R., Massa S., Pompei R., Artico M. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies. Bioorg. Med. Chem. 8:2000;1423-1432
22. Pagani G., Pregnolato M., Ubiali D., Terreni M., Piersimoni C., Scaglione F., Fraschini F., Rodriguez Gascon A., Pedraz Munoz J.L. Synthesis and in vitro anti-mycobacterium activity of N-alkyl-1, 2-dihydro-2-thioxo-3- pyridinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation. J. Med. Chem. 43:2000;199-204
23. Waisser K., Gregor J., Kubicova L., Klimesova V., Kunes J., Machacek M., Kaustova J. New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo- 2H-1, 3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1, 3-benzoxazine-2, 4(3H)-dithiones. Eur. J. Med. Chem. 35:2000;733-741
24. Bosi S., Da Ros T., Castellano S., Banfi E., Prato M. Antimycobacterial activity of ionic fullerene derivatives. Bioorg. Med. Chem. Lett. 10:2000;1043-1045
25. Selvakumar N., Srinivas D., Khera M.K., Kumar M.S., Mamidi R.N., Sarnaik H., Charavaryamath C., Rao B.S., Raheem M.A., Das J., Iqbal J., Rajagopalan R. Synthesis of conformationally constrained analogues of linezolid: structure-activity relationship (SAR) studies on selected novel tricyclic oxazolidinones. J. Med. Chem. 45:2002;3953-3962
26. Klimesova V., Koci J., Waisser K., Kaustova J. New benzimidazole derivatives as antimycobacterial agents. Farmaco. 57:2002;259-265
27. Gundersen L.L., Nissen-Meyer J., Spilsberg B. Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines. J. Med. Chem. 45:2002;1383-1386
28. Sanna P., Carta A., Gherardini L., Esmail M., Nikookar R. Synthesis and antimycobacterial activity of 3-aryl-, 3-cyclohexyl- and 3-heteroaryl- substituted-2-(1H(2H)-benzotriazol-1(2)-yl)prop-2-enenitriles, prop-2-enamides and propenoic acids. II. Farmaco. 57:2002;79-87
29. Biava M. BM 212 and its derivatives as a new class of antimycobacterial active agents. Curr. Med. Chem. 9:2002;1859-1869
30. Tomioka H. Prospects for development of new antimycobacterial drugs. J. Infect. Chemother. 6:2000;8-20. and references cited therein
31. Ashtekar D.R., Costa-Pereira R., Nagarajan K., Vishvanathan N., Bhatt A.D., Rittel W. In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis. Antimicr. Agents Chemother. 37:1993;183-186
32. O'Neill B.T., Busch F.R., Lehner R.S., Richard S. Preparation of nicotinoylacetates and analogs as intermediates for quinolonecarboxylate antibacterials. Eur. Pat. Appl. 1991;15. EP 449445 A2 19911002
33. Cecchetti V., Fravolini A., Palombo M., Sissi C., Tabarrini O., Terni P., Xin T. Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy. J. Med. Chem. 39:1996;4952-4957
34. Klopman G., Fercu D., Renau T.E., Jacobs M.R. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. Antimicrob. Agents Chemother. 40:1996;2637-2643
35. Renau T.E., Sanchez J.P., Gage J.W., Dever J.A., Shapiro M.A., Gracheck S.J., Domagala J.M. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7. J. Med. Chem. 39:1996;729-735
36. Pauwels R., Balzarini J., Baba M., Snoeck R., Sholds D., Herdewijn P., Deshyter J., De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods. 20:1988;309-321